Age: 55.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rhinorrhoea, SARS-CoV-2 test, SARS-CoV-2 test positive, Sinus congestion
Clinical narrative: Positive for Covid19. He has had five Pfizer Covid Vaccines.; Positive for Covid19. He has had five Pfizer Covid Vaccines.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old male patient received BNT162b2 (BNT162B2), on 25Feb2021 as dose 1, single (Lot number: EN-6198), in right arm, on 18Mar2021 as dose 2, single (Lot number: EP-7534), in left arm, on 17Aug2021 as dose 3 (booster), single (Lot number: FO181), in right arm, on 06Jan2022 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm and on 02Jun2022 as dose 5 (booster), single (Lot number: FM7553) at the age of 55 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing); "hypothyroid" (unspecified if ongoing), notes: hypothyroid; "Anxiety" (unspecified if ongoing); "Sleep" (unspecified if ongoing), notes: Sleep. Concomitant medication(s) included: ENBREL taken for rheumatoid arthritis, patient doctor told him not take his last dose. Clarified his rheumatologist said to skip last dose of Enbrel due to COVID, start date: 17Oct2020; LEVOTHYROXINE taken for hypothyroidism; CLONAZEPAM taken for anxiety, start date: 10Jan2020; TETRAHYDROCANNABINOLS NOS taken for sleep disorder, occasionally patient takes 5mg of THC Cannabis for sleep. stop date: 28Jun2022(last dose). The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset Jul2022, outcome "unknown" and all described as "Positive for Covid19. He has had five Pfizer Covid Vaccines.". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (09Jul2022) negative; (11Jul2022) negative; (12Jul2022) Positive, notes: two separate testing; (08Jul2022) negative; (12Jul2022) doesn't have the results, notes: two separate testing. Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: The patient was treated with Paxlovid on 04Jul2022 and date of last administration was 08Jul2022. He finished treatment and took all ten doses. Consumer on the line reporting possible COVID rebound with Paxlovid. He finished Paxlovid 08Jul2022 and tested negative with PCR on 08Jul2022. He took antigen testing 09Jul2022 and 11Jul2022 and was negative. On 12Jul2022, he got symptoms and tested positive on two separate testing. Patient was 147 pounds then states he might have lost some weight during COVID but he doesn't know. Patient told he had coughs when he goes up stairs.He got pretty sick with fourth dose. Because of Enbrel he hasn't felt this good since he was 20. It was an amazing drug. He was getting off the anxiety drug, Clonazepam. He had a bad thing happen in his life and that is why he was on Clonazepam, but he was tapering off. Other than having COVID he was doing well. He tried to go cold turkey off of Clonazepam and that was a bad choice.Additional Vaccines Administered on Same Date of the Pfizer Suspect: none. he did not have any additional vaccines when receiving any of the COVID vaccines. He is very good about vaccines, but only received the COVID vaccines on those dates.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.